Mergers & Acquisitions

Amneal, PL Developments intro store-brand equivalent of Voltaren Arthritis Pain
The companies are introducing their diclofenac sodium topical gel 1% in 50-, 100- and 150-g laminate tubes after receiving Food and Drug Administration approval, and are partnering to bring the product to U.S. retailers.
IRI acquires RSi
IRI said it expects its acquisition of RSi to enhance its supply chain optimization capabilities.

Rite Aid acquiring Bartell Drugs

Rite Aid is acquiring Bartell Drugs' 67 Seattle-area stores for $95 million, with plans for them to keep operating under the Bartell Drugs banner.
Omnicell acquires Pharmaceutical Strategy Group’s 340B software-enabled service business

Omnicell's acquisition of PSG's 340B Link business will help various healthcare entities manage compliance and capture 340B drug cost savings on outpatient prescriptions.
Bed Bath & Beyond’s same-store sales increase leads to improved Q2

Bed Bath & Beyond reported its first same-store sales gain in years fueled by surging e-commerce sales.
Bausch Health, Alfasigma resolve Xifaxan litigation with Sun Pharma

Salix will maintain market exclusivity for Xifaxan (rifaximin) 200 mg and 550 mg tablets until 2028.
Auxo acquires Euclid Medical

Auxo is making a foray into pharmaceutical packaging with the acquisition of Euclid Medical’s Precision Products Group brand.
SPARC licenses commercialization rights of Elepsia XR to Tripoint Therapeutics

Tripoint will commercialize SPARC's Elepsia XR tablets for five years, with the option to extend the agreement further.
Dr. Reddy’s settles Revlimid patent litigation with Celgene

Dr. Reddy's will be able to sell volume-limited amounts of generic lenalidomide capsules after March 2022, and an unlimited volume beginning Jan. 31, 2026.
Loblaw invests in virtual care provider Maple

Loblaw said that its $75 million investment in Maple comes as its Shoppers Drug Mart banner aims to make telehealth more accessible and focuses on a seamless move between virtual and in-person health care.

Amneal, PL Developments intro store-brand equivalent of Voltaren Arthritis Pain

IRI acquires RSi

Rite Aid acquiring Bartell Drugs

Omnicell acquires Pharmaceutical Strategy Group’s 340B software-enabled service business

Bed Bath & Beyond’s same-store sales increase leads to improved Q2

Bausch Health, Alfasigma resolve Xifaxan litigation with Sun Pharma

Auxo acquires Euclid Medical

SPARC licenses commercialization rights of Elepsia XR to Tripoint Therapeutics

Dr. Reddy’s settles Revlimid patent litigation with Celgene

Loblaw invests in virtual care provider Maple